Esophageal Cancer

Gastroenterology Clinics of North America

Volumn 37, Issue 4, 2008, Pages 943-964

  Siersema, Peter D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Ablative therapy; Adenocarcinoma; Brachytherapy; Endoscopic mucosal resection; Esophageal cancer; Palliation; Squamous cell carcinoma; Stent; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; LIQUID NITROGEN;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; DYSPHAGIA; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; EOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS EXAMINATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GENE EXPRESSION PROFILING; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOGENESIS; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SAFETY; SENSITIVITY AND SPECIFICITY; STENT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ESOPHAGEAL NEOPLASMS; HUMANS;

EID: 56349153161     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2008.09.012     Document Type: Review

References (60)

1. Siewert J.R., and Stein H.J. Classification of the adenocarcinoma of the oesophagogastric junction. Br J Surg 85 (1998) 1457-1459
2. Omloo J.M., Lagarde S.M., Hulscher J.B., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246 (2007) 992-1000 [discussion: 1000-1]
3. Chang A.C., Ji H., Birkmeyer N.J., et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 85 (2008) 424-429
4. Lemmens V.E.P.P., and Coebergh J.W.W. Epidemiology of gastrointestinal cancer: (trends in) incidence and mortality from esophageal, stomach, and colorectal cancer. In: Conio M., Siersema P.D., Repici A., and Ponchion T. (Eds). Endoscopic mucosal resection (2008), Blackwell Publishing, Malden, Oxford, Carlton 1-17
5. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
6. Botterweck A.A., Schouten L.J., Volovics A., et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29 (2000) 645-654
7. Wijnhoven B.P., Louwman M.W., Tilanus H.W., et al. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 14 (2002) 115-122
8. van Blankenstein M., Looman C.W., Siersema P.D., et al. Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989-2003. Br J Cancer 96 (2007) 1767-1771
9. van Soest E.M., Dieleman J.P., Siersema P.D., et al. Increasing incidence of Barrett's oesophagus in the general population. Gut 54 (2005) 1062-1066
10. Vaughan T.L., Davis S., Kristal A., et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4 (1995) 85-92
11. Lagergren J., Bergström R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
12. Thomas T., Abrams K.R., De Caestecker J.S., et al. Meta analysis: cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther 26 (2007) 1465-1477
13. Wong A., and Fitzgerald R.C. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 3 (2005) 1-10
14. de Jonge P.J., Steyerberg E.W., Kuipers E.J., et al. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 101 (2006) 1421-1429
15. Corley D.A., Kubo A., and Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 17 (2008) 352-358
16. Hao Y., Triadafilopoulos G., Sahbaie P., et al. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 131 (2006) 925-933
17. Wallace M.B., Hawes R.H., Sahai A.V., et al. Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management. Gastrointest Endosc 51 (2000) 309-313
18. Kutup A., Link B.C., Schurr P.G., et al. Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy 39 (2007) 715-719
19. Lal N., Bhasin D.K., Malik A.K., et al. Optimal number of biopsy specimens in the diagnosis of carcinoma of the oesophagus. Gut 33 (1992) 724-726
20. van Vliet E.P., Heijenbrok-Kal M.H., Hunink M.G., et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 98 (2008) 547-557
21. van Westreenen H.L., Westerterp M., Sloof G.W., et al. Limited additional value of positron emission tomography in staging oesophageal cancer. Br J Surg 94 (2007) 1515-1520
22. van Vliet E.P., Eijkemans M.J., Kuipers E.J., et al. A comparison between low-volume referring regional centers and a high-volume referral center in quality of preoperative metastasis detection in esophageal carcinoma. Am J Gastroenterol 101 (2006) 234-242
23. van Vliet EP, Hermans JJ, de Wever W, et al. Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer. Eur Radiol 2008 Jun 4 [Epub ahead of print].
24. Fockens P., van den Brande J.H., van Dullemen H.M., et al. Endosonographic T-staging of esophageal carcinoma: a learning curve. Gastrointest Endosc 44 (1996) 58-62
25. Schlick T., Heintz A., and Junginger T. The examiner's learning effect and its influence on the quality of endoscopic ultrasonography in carcinoma of the esophagus and gastric cardia. Surg Endosc 13 (1999) 894-898
26. van Vliet E.P.M., Eijkemans M.J.C., Poley J.W., et al. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. Gastrointest Endosc 63 (2006) 938-947
27. Westerterp M., Koppert L.B., Buskens C.J., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 446 (2005) 497-504
28. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
29. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117-2127
30. Hage M., Siersema P.D., and van Dekken H. Oesophageal pathology following ablation of Barrett's mucosa. Curr Diagn Pathol 12 (2006) 127-135
31. Ganz R.A., Overholt B.F., Sharma V.K., et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 68 (2008) 35-40
32. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 (2007) 185-195
33. Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008 Jun 16 [Epub ahead of print].
34. Seewald S., Omar S., and Soehendra N. Endoscopic mucosectomy of the esophagus. Am J Gastroenterol 102 (2007) 236-238
35. Pech O., May A., Rabenstein T., et al. Endoscopic resection of early oesophageal cancer. Gut 56 (2007) 1625-1634
36. May A., Gossner L., Behrens A., et al. A prospective randomized trial of two different suck-and-cut mucosectomy techniques in 100 consecutive resections in patients with early cancer of the esophagus. Gastrointest Endosc 58 (2003) 167-175
37. Ono H., Kondo H., Gotoda T., et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48 (2001) 225-229
38. Hosokawa K., and Yoshida S. [Recent advances in endoscopic mucosal resection for early gastric cancer]. Gan To Kagaku Ryoho 25 (1998) 476-483 (In Japanese)
39. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 65 (2007) 3-10
40. Peters F.P., Kara M.A., Rosmolen W.D., et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. Am J Gastroenterol 101 (2006) 1449-1457
41. Lopes C.V., Hela M., Pesenti C., et al. Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc 21 5 (2007) 820-824
42. Pech O, Behrens A, May AD, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008 May 6 [Epub ahead of print].
43. Siersema P.D., and van Hillegersberg R. Treatment of locally advanced esophageal cancer with surgery and chemoradiation. Curr Opin Gastroenterol 24 (2008) 535-540
44. Graham A.J., Shrive F.M., Ghali W.A., et al. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg 83 (2007) 1257-1264
45. Kim M.K., Kim S.B., Ahn J.H., et al. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 71 (2008) 725-734
46. Matsuyama J., Doki Y., Yasuda T., et al. The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus. Surgery 141 (2007) 570-580
47. Shimada H., Shiratori T., Okazumi S., et al. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience. J Am Coll Surg 206 (2008) 48-56
48. De Manzoni G., Pedrazzani C., Pasini F., et al. Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. J Surg Oncol 95 (2007) 261-266
49. Al-Sarraf M., Martz K., Herskovic A., et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15 (1997) 277-284
50. Bedenne L., Michel P., Bouché O., et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25 (2007) 1160-1168
51. Gardner-Thorpe J., Hardwick R.H., and Dwerryhouse S.J. Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 94 (2007) 1059-1066
52. Vakil N., Morris A.I., Marcon N., et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96 (2001) 1791-1796
53. Homs M.Y., and Siersema P.D. Stents in the GI tract. Expert Rev Med Devices 4 (2007) 741-752
54. Verschuur E.M., Repici A., Kuipers E.J., et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 103 (2008) 304-312
55. Conio M., Repici A., Battaglia G., et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 102 (2007) 2667-2677
56. Verschuur E.M., Kuipers E.J., and Siersema P.D. Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 66 (2007) 1082-1090
57. Shim C.S., Jung I.S., Bhandari S., et al. Management of malignant strictures of the cervical esophagus with a newly-designed self-expanding metal stent. Endoscopy 36 (2004) 554-557
58. Homs M.Y., Eijkenboom W.M., Coen V.L., et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol 66 (2003) 327-332
59. Homs M.Y., Steyerberg E.W., Eijkenboom W.M., et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364 (2004) 1497-1504
60. Steyerberg E.W., Homs M.Y., Stokvis A., et al. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc 62 (2005) 333-340